Therapeutics Acquisition ... (RACA)
NASDAQ: RACA
· Real-Time Price · USD
10.27
0.24 (2.39%)
At close: Jul 01, 2021, 6:00 AM
Company Description
Therapeutics Acquisition Corp., doing business as Research Alliance Corp.
I, intends to effect a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the healthcare industry in the United States.
The company was founded in 2020 and is based in Boston, Massachusetts.
Therapeutics Acquisition Corp.
| Country | United States |
| IPO Date | Aug 7, 2020 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Peter Kolchinsky |
Contact Details
Address: 200 Berkeley Street Boston, Massachusetts United States | |
| Website | http://www.researchalliancecorp.com |
Stock Details
| Ticker Symbol | RACA |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001811764 |
| CUSIP Number | |
| ISIN Number | |
| Employer ID | 85-0800493 |
| SIC Code | 2834 |
Key Executives
No executives data available.Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 08, 2024 | 15-12G | Filing |
| Dec 27, 2023 | 4 | Filing |
| Dec 27, 2023 | 4 | Filing |
| Dec 27, 2023 | 4 | Filing |
| Dec 27, 2023 | 4 | Filing |
| Dec 27, 2023 | 4 | Filing |
| Dec 27, 2023 | 4 | Filing |
| Dec 27, 2023 | 4 | Filing |
| Dec 27, 2023 | 4 | Filing |
| Dec 27, 2023 | 4 | Filing |